Table 2 Baseline patient characteristics
From: Public sector low threshold office-based buprenorphine treatment: outcomes at year 7
All patients (N = 485) n (%) | Inductionsa (n = 306) n (%) | Transfersa (n = 179) n (%) | |
|---|---|---|---|
Mal | 402 (83) | 256 (84) | 146 (82) |
Age, average (range) | 47 (23–73) | 47 (24–71) | 47 (24–73) |
Race and ethnicityb | |||
Black | 140 (29) | 107 (35)* | 33 (18) |
Hispanic | 60 (12) | 38 (12) | 22 (12) |
White | 147 (30) | 76 (25)* | 71 (40) |
Insurance statusc | |||
Medicaid | 294 (61) | 193 (64) | 101 (56) |
Commercial | 39 (8) | 15 (5)* | 24 (13) |
Medicare | 11 (2.5) | 6 (2) | 5 (3) |
Uninsured/self pay | 113 (23) | 71 (22) | 42 (24) |
Unemployed | |||
Homeless (shelter or street)d | 80 (16) | 64 (21)* | 16 (9) |
History of Incarceratione | 338 (70) | 227 (74)* | 111 (62) |
Hepatitis C positive, self-report | 152 (31) | 95 (30) | 57 (40) |
HIV positive, self-report | 47 (10) | 32 (10) | 15 (10) |
Opioid use | |||
Heroin use, last 7 days | 252 (52) | 220 (72)* | 32 (18) |
Heroin use, lifetime | 444 (92) | 289 (94)* | 155 (87) |
Prescription opioid misuse, last 7 days | 105 (22) | 88 (29)* | 17 (10) |
Prescription opioid Misuse, lifetime | 274 (56) | 174 (57) | 100 (56) |
IV drug use, last 7 days | 104 (22) | 88 (29)* | 16 (9) |
Buprenorphine, previous illicit or licit use | 368 (76) | 199 (65)* | 179 (100) |
Methadone maintenance, previous | 295 (61) | 191 (62) | 104 (63) |
Methadone maintenance, current | 26 (7) | 26 (8)* | 0 (0) |
Other drug use | |||
Cocaine use, last 7 days | 102 (21) | 76 (25)* | 26 (15) |
Benzodiazepine use, last 7 days | 57 (12) | 36 (12) | 21 (12) |
Cannabis use, last 7 days | 83 (17) | 53 (17) | 30 (18) |
Heavy drinking (>5 drinks per occasion), last 12 months | 125 (26) | 85 (28) | 40 (24) |
Smoking, current | 391 (81) | 252 (82) | 139 (78) |